The Joplin City Council will act at a meeting Monday on a resolution that would designate Joplin as "Blue Shield City" for public safety.

The finalists of FNB Varsity Shield 2025 have been decided, with FNB Varsity College set to face FNB Madibaz on 11 April at ...

Pacira BioSciences PCRX announced that it has dosed the first patient in a mid-stage study of pipeline candidate PCRX-201 ...

The trial is structured to assess the safety and efficacy of the therapy in approximately 50 ATTRv-PN subjects.

Two startups focused on individual coverage health reimbursement arrangement plans received funding this week.

The "General Dynamics Land Systems - Strategy Playbook - 2025 - Strategy Focus, Key Strategies & Plans, SWOT, Trends & Growth Opportunities, Market Outlook" company profile has been added to ...

Axsome Therapeutics said it's dopamine and norepinephrine reuptake inhibitor solriamfetol (Sunosi), approved for excessive ...

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a leading muscle disease biopharmaceutical company, today announced the pricing of an underwritten offering of 9,935,419 shares of its common stock at an ...

The recent inauguration of GE Aerospace-Lufthansa Technik joint venture XEOS’ CFM International Leap maintenance and testing facility is the latest ramp-up in the narrowbody engine’s aftermarket ...

Cash and cash receivable balance of $20.9 million as of December 31, 2024, expected to fund operations, including clinical activities into 2027Strengthened cash position expected to support ...

Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...

Axsome's Phase 3 trial for solriamfetol in MDD did not meet its primary endpoint, but positive data in severe EDS patients ...